Multiple ALK point mutations have been identified in neuroblastoma, however, not all of them are classified as gain-of-function mutations, as some of the mutations are kinase dead and some seem to behave (at least in terms of activation) as wild type ALK [3]. This evidence concerns the gene ALK and neuroblastoma.